Ugo Falagario
Icahn School of Medicine at Mount Sinai
CancerInternal medicineRadiologyUrologySurgeryMagnetic resonance imagingOncologyLogistic regressionBiopsyProstateProstatectomyProstate cancerNephrectomyBladder cancerProstate biopsyPopulationMultiparametric Magnetic Resonance ImagingIn patientNomogramConfidence intervalMedicine
Publications 87
#1Alberto MartiniH-Index: 27
#2Ugo Falagario (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 8
Last. Ashutosh K. Tewari (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 44
view all 8 authors...
BACKGROUND mpMRI can provide important information for surgical planning, yet its interpretation is not immediate and imaging consultation at the time of surgery can result in interruptions and delay. The use of 3D models based on mpMRI, might obviate these issues. We aimed to evaluate the role of the prospective integration of 3D models from mpMRI in the robotic console in reducing the rate of PSMs. MATERIAL AND METHODS PSMs at our center are evaluated intraoperatively using the NeuroSAFE metho...
Radiomics and genomics represent two of the most promising fields of cancer research, designed to improve the risk stratification and disease management of patients with prostate cancer (PCa). Radiomics involves a conversion of imaging derivate quantitative features using manual or automated algorithms, enhancing existing data through mathematical analysis. This could increase the clinical value in PCa management. To extract features from imaging methods such as magnetic resonance imaging (MRI),...
#1P. TreacyH-Index: 1
#2Matthieu DurandH-Index: 13
Last. Imad BentellisH-Index: 2
view all 17 authors...
#1Ugo FalagarioH-Index: 8
#2Oscar SelvaggioH-Index: 13
Last. Bernardo RoccoH-Index: 33
view all 12 authors...
#2Gian Maria BusettoH-Index: 19
Last. Eila C. SkinnerH-Index: 61
view all 11 authors...
#1Ugo FalagarioH-Index: 8
#2Alberto MartiniH-Index: 27
view all 19 authors...
#1Gian Maria BusettoH-Index: 19
#2Antonella CormioH-Index: 15
Last. Luigi CormioH-Index: 19
view all 7 authors...
#1Oscar Selvaggio (University of Foggia)H-Index: 13
#2Ugo Falagario (University of Foggia)H-Index: 8
Last. Rafael Sanchez-SalasH-Index: 24
view all 15 authors...
Partial gland cryoablation (PGC) aims at destroying prostate cancer (PCa) foci while sparing the unaffected prostate tissue and the functionally relevant structures around the prostate. Magnetic Resonance Imaging (MRI) has boosted PGC, but available evidence suggests that ablation margins may be positive due to MRI-invisible lesions. This study aimed at determining the potential role of intraoperative digital analysis of ablation margins (DAAM) by fluoresce confocal microscopy (FCM) of biopsy co...
#1Antonella Cormio (University of Bari)H-Index: 15
#2Gian Maria Busetto (University of Foggia)H-Index: 19
Last. Luigi Cormio (University of Foggia)H-Index: 19
view all 0 authors...
Identification of markers predicting disease outcome is a major clinical issue for non-muscle invasive bladder cancer (NMIBC). The present study aimed to determine the role of the mitochondrial proteins Mitofusin-2 (Mfn2) and caseinolytic protease P (ClpP) in predicting the outcome of NMIBC. The study population consisted of patients scheduled for transurethral resection of bladder tumor upon the clinical diagnosis of bladder cancer (BC). Samples of the main bladder tumor and healthy-looking bla...
#1Vinayak G. Wagaskar (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 4
#2Ankur Mittal (AIIMS: All India Institute of Medical Sciences)H-Index: 3
Last. Ash Tewari (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 11
view all 17 authors...
Abstract Background A common side effect following radical prostatectomy is urinary incontinence. Here, we describe a novel surgical technique to reduce postoperative urinary incontinence and facilitate early return of continence. Objective To describe the novel “hood technique” for robotic-assisted radical prostatectomy (RARP). Design, setting, and participants This is an institutional review board–approved prospective study of 300 patients (median age 64 yr) with localized prostate cancer trea...
5 CitationsSource